Orforglipron Added to Titrated Insulin Glargine in Type 2 Diabetes
This randomized trial assesses the effect of adding orforglipron to titrated insulin glargine on 40-week change in hemoglobin A1c (HbA1c) among patients with type 2 diabetes inadequately controlled by insulin glargine.
Original Source
Read the full article at Jamanetwork →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.